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At least wo of the introns in the antithrombin-III (AT-III) gene are located in positions different from those 
of the other three proteins in this superfamily for which the gene structures are known, namely, ovalbumin, 
cr,-antitrypsin a d angiotensinogen. In another part of the 3’-portion of the AT-III gene there is no intron 
where ach of the other three gene structures has one. 
Antithrombin-III superfamily 
1. INTRODUCTION 
Antithrombin-III (AT-III, heparin cofactor) in- 
hibits most of the serine proteinases involved in 
blood clotting (review [l]). Its primary structure 
was determined in 1977 [2]. The amino acid se- 
quence has also been deduced from cDNA se- 
quences [3-51. Other serine proteinase inhibitors 
from blood plasma, namely ui-antitrypsin [6] and 
cYr-antichymotrypsin [7], ovalbumin from hen egg 
white [8,9], angiotensinogen from blood plasma 
[lo, 1 l] and Z-protein from barley endosperm [12] 
have turned out to have amino acid sequences 
which are sufficiently homologous with that of 
AT-III to prove that all these proteins belong to 
the same superfamily. The gene structures of some 
of the members of this superfamily have been 
elucidated, namely those of ovalbumin [ 131, 
al-antitrypsin [ 141 and angiotensinogen [ 151. 
Because of the distant evolutionary origin and ap- 
parently different functions of at least some of 
these proteins it is interesting to compare the gene 
structures in this superfamily of proteins. In 
essence that of ovalbumin with 7 exons has turned 
out to be quite significantly different from those of 
ar-antitrypsin and angiotensinogen, which on the 
other hand are mutually quite similar [ 151. 
In a study of a gene clone of human 
antithrombin-III we have now found that at least 
part of the AT-III gene near the 3 ’ -end is quite dif- 
Zntron Homology 
ferent not only from that of ovalbumin but also 
from those of ar-antitrypsin and angiotensinogen. 
2. MATERIALS AND METHODS 
2.1. Cloning of the A T-III gene 
The cosmid pHC79-H-AT-III with a 32.4 kbp 
insert containing the AT-III gene was a kind gift 
from Dr S.L. Woo. Its isolation is to be published 
elsewhere (S.L. Woo et al., in preparation). 
2.2. Isolation of subclones 
The pHC79-H-AT-III cosmid was transformed 
into competent E. coli 8767 and cosmid DNA was 
prepared using standard procedures [16]. The 
DNA was digested with EcoRI (Boehringer, 
Mannheim) and the EcoRI fragments were eluted 
from preparative agarose gels using the procedure 
of Dretzen et al. [17] or with DEAE paper 
(Schleicher and Schuell, Dassel, FRG) using the 
directions of the manufacturer. The isolated 
EcoRI fragments were ligated into pBR328 [18] 
which had been linearized with EcoRI and treated 
with alkaline phosphatase (Boehringer). The 
plasmids were then transformed into competent 
E. coli K803 [ 161. Those recombinant clones were 
selected which grow on agar plates with tetra- 
cyclin, but not chloramphenicol, since the EcoRI 
site in pBR328 is located in the chloramphenicol 
resistance gene. Recombinant clones containing an 
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insert of 2.4 kbp were grown on a large scale 
(pA2.4) as were the clones with inserts of 4.7 kbp 
(pA4.7) and 3.8 kbp (pA3.8) [16]. 
2.3. Restriction mapping 
The mapping of pHC79-H-AT-III with EcoRI, 
Hind111 and BamHI is to be published elsewhere 
(S.L. Woo et al., in preparation). The pA2.4, 
pA4.7 and pA3.8 subclones were mapped by a 
combination of single and double enzyme diges- 
tions. The digests were examined by agarose gel 
electrophoresis and compared with digests of 
pBR328 obtained with the same enzyme 
combinations. 
2.4. PstZ/EcoRZ Ml3 clones 
The pA4.7 and pA3.8 clones were digested with 
PstI and EcoRI and fragments were eluted from an 
agarose gel as described already (0.4 kbp from 
pA4.7 and 0.5 kbp from pA3.8). The fragments 
were ligated into M13mp8 and M13mp9 (which 
had been digested with PstI and EcoRI) and 
transformed into competent E. coli JM103 [16]. 
2.5. FnuDZ/BcoRZ Ml3 clones 
The pA4.7 clone was digested with EcoRI and 
the insert of 4.7 kbp was eluted from an agarose 
gel. The fragment was digested with FnuDI 
(Biolab), ligated into M13mp8 (digested with SmaI 
(Biolab) and EcoRI) and transformed into compe- 
tent E. coli JM103. 
Single-stranded DNA was prepared from recom- 
binant Ml 3 plaques using standard procedures [161 
and sequenced by the dideoxy method [19] using 
the standard 15mer primer, which was a kind gift 
from R. Garrett, University of Aarhus. 
3. RBSULTS AND DISCUSSION 
The insert of the cosmid pHC79-H-AT-III con- 
tains the coding part of the human AT-III gene 
(mapped in fig.1). The EcoRI fragments were 
subcloned and partly sequenced. Restriction map- 
ping and DNA sequencing of the clones containing 
the 4.7 kb EcoRI fragment (pA4.7) and the 3.8 kb 
EcoRI fragment (pA3.8) showed the position of 2 
introns in the 3 ‘-end of the gene. The sequences 
around the PstI site in pA4.7 and from the 3 ‘-end 
of the insert of pA3.8 are shown in fig.2A and B 
and compared with the corresponding parts of the 
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Fig.1. Restriction map of part of the insert of the 
pHC79-H-AT-III cosmid clone containing the coding 
part of the antithrombin-III gene. The numbers refer to 
the sizes of the EcoRI fragments in kbp. The arrows 
indicate the areas sequenced. In the 4.7 kbp fragment 
there is an FnuDI site (not shown) 125 bp upstream from 
the PstI site. This FnuDI site was used for subcloning the 
DNA into MI3 for sequencing (see section 2). 
cDNA sequence published by Chandra et al. [5]. 
The sequenced areas are shown with arrowheads in 
fig.1. The sequences how the presence of 2 in- 
trons, at positions 1153 (fig.2A) and 1218 (fig.2B), 
in the cDNA sequence of AT-III. They also show 
that there are no introns present in that part of the 
AT-III gene which corresponds to the base stret- 
ches 882-1153 and 1218-1442 in the cDNA of AT- 
III. 
There are 2 silent A-to-G transitions corre- 
sponding to positions 981 and 1011 in the cDNA 
sequence [5]. The latter creates the PstI site used in 
the sequence determination and was observed as a 
polymorphism in the cDNA sequence of Pro- 
chownik et al. [4]. 
The positions of the 2 introns in the AT-III gene 
identified here correspond to the positions after 
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A 
262 
RVAEGTQVLELPFKGDDITM 
CGCCTGGCTGAAGGCACCCAGGTGCTTGAGTTGCCCTTCAAAGGTGATGACATCACCATG 
880 
VLILPKPEKSLAKVEKELTP 
GTCCTCATCTTGCCCAAGCCTGAGAAGAGCCTGGCCAAGGTGGAGAAGGAACTCACCCCA 
9'10 
EVLDEWLDELEEMMLVVHMP 
GAGGTGCTGCAGGAGTGGCTGGATGAATTGGAGGAGATGATGCTGGTGGTCCACATGCCC 
,000 
RFRIEDGFSLKEQLQDMGLV 
CGCTTCCGCATTGAGGACGGCTTCAGTTTGAAGGAGCAGCTGCAAGACATGGGCCTTGTC 
1060 
DLFSPEKSKLPG 
CATCTGTTCAGCCCTGAAAAGTCCAAACTCCCAGgtttgtctaggaaggagtttcctccc 
,120 
ttctccacccg 
B 
375 
VNEEGSEAAASTAVVIAG 
gtg:2aQ9GTAAATGAAGAAGGCAGTGAAGCAGCTGCAAGTACCGCTGTTGTGATTGCTGGC 
R 5 L N P N R V T F K A N R P F L V Fl 
,2,~GTTCGCTAAACCCCAACAGGGTGACTTTCAAGGCCAACAGGCCTTTCCTGGTTTTTATA 
REVPLNTIIFMGRVANPCVK 
AGAGAAGTTCCTCTGAACACTATTATCTTCATGGGCAGAGTAGCCAACCCTTGTGTTAAG 
1333 
*** 
TAAAATGTTCTTATTCTTTGCACCTCTTCCTATTTTTGGTTTGTGAACAG 
1393 
Fig.2. (A) Partial nucleotide sequence of the pA4.7 
subclone containing part of the human antithrombin-III 
gene. The sequence corresponds to bases 880-1153 in 
the cDNA sequence [5], coding for amino acid residues 
262-353 [2], followed by the sequence of the first 37 
bases of the intron at position 1153. (B) Partial 
nucleotide sequence of the pA3.8 subclone, containing 
the last 6 bases of the intron at position 1219 of the 
cDNA [5]. This area codes for the last part of AT-III 
(residues 375-432) and contains 47 bases of the 3’-non- 
coding region. The stop codon is marked with 3 
asterisks. 
This area contains the primary proteinase inhibitor 
sites of AT-III and a,-antitrypsin and the 
subtilisin-susceptible site in ovalbumin cleaved 
during conversion to plakalbumin [20,21]. Of the 
2 introns found at positions in the gene corre- 
sponding to residues 352 and 374 in the C-terminal 
part of AT-III, neither has an equivalent in any of 
the genes for the other 3 proteins. 
the first base of Gly-352 and between Glu-374 and Previous results showed that genes coding for 
Val-375 in the amino acid sequence. In fig.3 an members of this superfamily of proteins have 2 dif- 
alignment is shown of the C-terminal part of the ferent intron patterns, one for ovalbumin and 
protein sequences of angiotensinogen [lo], another for cY1-antitrypsin and angiotensinogen. 
aI-antitrypsin [6], ovalbumin [8] and AT-III [2] Our results provide evidence showing that the in- 
with the positions of their introns [13-151. The tron pattern for antithrombin-III is different from 
area between amino acid residues 262 and 352 in the others, thus adding new information to the cur- 
AT-III is all encoded on one exon, whereas the cor- rent discussion of evolutionary origin of introns 
responding area is interrupted by one intron in [22,23] favouring the opinion that introns are of 
each of the other 3 members of the superfamily. relatively late origin [22]. 
-lO- 
ii7 
AGTH AGEEFOpT---ESAOOPLSPEvLDVTtSSPFLFAIYEHDSGALHFtGRV~NPQNvv 
33% 
PlPT ~GTEAAGA---?~FLEAIPEISIPPEV~F~~~PFVFL~I~E~NTKSPLF~~GKVVNPTOK 
135 
OVCH ALHEVVGS---AEAGYOAASYSEEFKADHPFLFCIKH~R~NAVLFFGRCVSP 
$3) 
AT-III ~GsEAAASTAYYIAGRSLNPNRYTFKAflKPFLYFIREVP~NTllFMGRVANPcvh 
Fig.3. Alignment (as in [ 111) of the amino acid sequence 
of residues 261-432 of human antithrombin-III (AT-III) 
with the homologous stretches of rat angiotensinogen 
(AGTR) (residues 3 13-477), human cyl-antitrypsin 
(AlAT) (residues 230-394) and chicken ovalbumin 
(OVCH) (residues 220-385). Intron positions are 
marked with arrowheads. 
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